Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FS8YB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,228
Award facts
- Contract value 100% obligated
- $22,228.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This contract award represents a delivery order issued by the Defense Logistics Agency (DLA) to AmerSourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) valued at $22,228.30. The award, made on February 3, 2026, with an ultimate completion date of February 4, 2026, was competitively awarded with no set-aside designation. AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. This delivery order is executed under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026, which enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerSourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerSourceBergen), which serves as the parent organization and holds the primary IDC with DLA. The contract utilizes firm fixed-price pricing and represents routine pharmaceutical procurement for federal military medical supply chain operations. Eliquis, an anticoagulant medication commonly prescribed for stroke prevention and blood clot treatment, is part of the extensive portfolio of specialty and brand-name medications that AmerSourceBergen supplies to defense and veteran healthcare systems through its DLA partnership.
Quick answers
Who was awarded contract SPE2DR26FS8YB?
SPE2DR26FS8YB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26FS8YB worth?
The government has obligated $22,228 on SPE2DR26FS8YB.
Is contract SPE2DR26FS8YB an order under another contract?
Yes. SPE2DR26FS8YB is a delivery order under SPE2DR25D3021, an indefinite delivery contract.
Was contract SPE2DR26FS8YB competed?
The extent of competition for SPE2DR26FS8YB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award